by rss feed | May 1, 2026 | CBER, FDA, Katherine Szarama, News Feeds
Yesterday was Vinay Prasad’s last day as the Director of CBER, the FDA’s biologics branch and as of today Katherine Szarama is Acting Director. Is there some significance to Szarama being acting director? It’s hard to say. Most signs seem to suggest...
